Clinical trial · Interventional
Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck
NCT03139058CI-TRIAL-00115906fibr'HOMterminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Recruitment difficulties
Summary
Brief summary (as posted)
Tobacco and alcohol are the two major risk factors for upper respiratory tract cancer (VADS).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cirrhoses | — | UNRESOLVED | — |
| Liver Fibroses | — | UNRESOLVED | — |
| Squamous Cell Carcinoma of the Head and Neck | Head and Neck Squamous Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Evaluation of the hepatic fibrosis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- prevalence of cirrhosis
- description
- Study the prevalence of cirrhosis in patients with VADS cancer
- interventionNames
- Other: Evaluation of the hepatic fibrosis
Primary outcomes (1)
- measure
- Determine the prevalence, by registry data analysis, of cirrhosis in patients with VADS cancer
- timeFrame
- 1 day
- description
- Determine the prevalence, by registry data analysis, of cirrhosis in patients with VADS cancer
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient over 18 years of age * Supported in the department of Orl \& CCF or Maxillo-Faciale surgery of the CHU d'Amiens * Histological diagnosis of epidermoid carcinoma: * From the oral cavity * From the oropharynx * Hypopharynx * Larynx * Any stage of cancer * Affiliation to a social security scheme Exclusion Criteria: * Patient already treated previously for a cancer of the VADS * Patient referred to in Articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the Public Health Code
References
Publications (0)
Data not yet available
No reference posted for this study.